Agnès Poirier
- Oncology top 5%
- Pharmacology top 1%
- Pediatrics, Perinatology and Child Health top 5%
- Molecular Biology
- Genetics top 5%
- Co-authors
- Christoph FunkThierry LavéXiaoyan ChuRenée PortmannMohammed UllahKatja HeinigBo FengEva Gil Berglund
- Topics
- Drug Transport and Resistance Mechanisms (15 papers)Pharmacogenetics and Drug Metabolism (10 papers)Pharmacological Effects and Toxicity Studies (6 papers)
- Cited by
- PharmacologyOncologyGenetics
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Agnès Poirier
21 papers receiving 868 citations
Peers
Comparison fields: 5 of 79
- Oncology 521
- Pharmacology 306
- Pediatrics, Perinatology and Child Health 303
- Molecular Biology 254
- Genetics 172
Countries citing papers authored by Agnès Poirier
This map shows the geographic impact of Agnès Poirier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Poirier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Poirier more than expected).
Fields of papers citing papers by Agnès Poirier
This network shows the impact of papers produced by Agnès Poirier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Poirier. The network helps show where Agnès Poirier may publish in the future.
Co-authorship network of co-authors of Agnès Poirier
This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Poirier. A scholar is included among the top collaborators of Agnès Poirier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Poirier. Agnès Poirier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 114 | |
| 3 | 74 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 11 | |
| 7 | 37 | |
| 8 | 12 | |
| 9 | 21 | |
| 10 | 36 | |
| 11 | 24 | |
| 12 | 104 | |
| 13 | 151 | |
| 14 | 14 | |
| 15 | 30 | |
| 16 | 61 | |
| 17 | 49 | |
| 18 | 80 | |
| 19 | New strategies to address drug-drug interactions involving OATPs. | 49 |
| 20 | [Neurotensin, a multi-action peptide hormone]. | 3 |
About Agnès Poirier
Agnès Poirier is a scholar working on Pharmacology, Oncology and Genetics, having authored 21 papers that have together received 886 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Pharmacological Effects and Toxicity Studies (6 papers). The work is most often cited by research in Pharmacology (306 citations), Oncology (521 citations) and Genetics (172 citations). Agnès Poirier has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Christoph Funk, Thierry Lavé, Xiaoyan Chu, Renée Portmann, Mohammed Ullah, Katja Heinig, Bo Feng, Eva Gil Berglund, L Zhang and Joseph W. Polli. Their work appears in journals such as Neurology, Biochemical Pharmacology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.